Overview

APAP +/- Oxycodone

Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
This is an emergency department based randomized study of oxycodone/ acetaminophen versus acetaminophen alone for patients with acute musculoskeletal pain refractory to ibuprofen
Phase:
Phase 4
Details
Lead Sponsor:
Montefiore Medical Center
Treatments:
Acetaminophen
Acetaminophen, hydrocodone drug combination
Oxycodone